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Background. This study was designed to evaluate the effect of adding dexamethasone to epidural bupivacaine on postoperative
analgesia in unilateral inguinal herniorrhaphy.Methods. Forty-four patients were enrolled in this double-blind, clinical trial study.
Patients were randomly allocated into dexamethasone or control group. In the dexamethasone group, patients received 18ml of
bupivacaine 0.5% and 2ml (8mg) of dexamethasone; in the control group, patients received 18ml of bupivacaine 0.5% and 2ml of
normal saline. The onset of sensory block and its duration and incidence of nausea and vomiting were recorded. Results. The onset
of epidural anesthesia was significantly more rapid in the dexamethasone group than in the control group (𝑃 < 0.001). Duration
of analgesia was markedly prolonged in the dexamethasone group than in the control group (𝑃 < 0.001). Five patients (22.7%) in
the control group had nausea in the first hour after the procedure (𝑃 = 0.048). None of the patients in the dexamethasone group
had nausea. None of our patients had vomiting in the two groups. Conclusions. This study showed that adding dexamethasone to
bupivacaine significantly prolongs the duration of postoperative analgesia. This trial is registered with Iranian Registry of Clinical
Trials (IRCT) number IRCT2012062910137N1.
1. Introduction
Uncontrolled postoperative pain may produce a range of
harmful effects [1]. Attenuation of postoperative pain may
decrease perioperative mortality and morbidity [2]. Epidural
anesthesia and analgesia are a safe and effective method for
control of postoperative pain [3]. Prolonging the duration
of local anesthesia is often desirable because it produces
analgesia in the postoperative period.
Various adjuvants have been used to prolong epidural
anesthesia. The combination of epidural opioid and local
anesthetic provides good pain control during the first postop-
erative day but is associated with nausea, vomiting, sedation,
pruritus, urinary retention, and respiratory depression [4].
Several studies reveal that the addition of dexamethasone
to bupivacaine significantly prolongs the duration of the
motor block and improves the quality of analgesia following
interscalene and supraclavicular block [5–9]. Another study
revealed that epidural bupivacaine-dexamethasone mixture
had almost the same analgesic potency as bupivacaine-
fentanyl with opioid-sparing and antiemetic effects [10].
In this study, we evaluated the effect of adding dexam-
ethasone to epidural bupivacaine on the onset anesthesia and
duration of analgesia after unilateral inguinal herniorrhaphy.
2. Methods
Forty-four patients undergoing elective unilateral inguinal
herniorrhaphy, class 1 or 2 of the ASA (American Society of
Anesthesiology), were admitted to Shahid Beheshti Hospital
of Kashan University of Medical Sciences (KAUMS) from
May 2012 to March 2013 and were enrolled in this ran-
domized, double-blind, clinical trial study. After institutional
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Table 1: Demographic parameters in two groups.
Characteristics Dexamethasone group (𝑛 = 22) Control group (𝑛 = 22) 𝑃 value
Age (year) 46.09 ± 13.34 48.64 ± 13.83 0.54
ASA I (number) 21 (95.5%) 20 (90.9%) 0.55
ASA II (number) 1 (4.5%) 2 (9.1%) 0.55
Duration of surgery (minute) 76.3 ± 12.7 78.1 ± 12.4 0.55
Table 2: Clinical variables in two groups.
Characteristics Dexamethasone group (𝑛 = 22) Control group (𝑛 = 22) 𝑃 value
Onset of epidural anesthesia (minute) 7.64 ± 2.74 12.09 ± 2.79 <0.001
Duration of analgesia (minute) 692.55 ± 245.88 286.59 ± 84.02 <0.001
Nausea 0 5 (22.7%) 0.048
Vomiting 0 0 —
approval and approval by ethics committee of the university,
informed consent was obtained from each patient before
inclusion in the study.
Patients with complicated inguinal hernia (e.g., incarcer-
ated and strangulated), peptic ulcer disease, diabetesmellitus,
coagulopathies, skin infection on lumbar spine, severe or
morbid obesity, and renal or liver disease, those with allergy
to local anesthetics, and those on long-term steroid therapy
were excluded from the study.
Patients were randomly allocated into dexamethasone
or control group using block randomization. Patients and
an anesthesiologist who performed epidural anesthesia were
blind to the patients’ group allocation. After arrival at the
operating room, the study protocol and the epidural proce-
dure were explained to each patient. Standard monitoring
(pulse oximetry, electrocardiography, and noninvasive blood
pressuremonitoring) was established. Intravenous access was
secured and each patient received 10ml/kg of intravenous
normal saline during 30 minutes.
Single-shot epidural anesthesia was performed under
aseptic conditions with patients in the sitting position, using
“loss of resistance technique” and “18G Tuohy needle,” at the
L2-3 level, after skin infiltrationwith lidocaine 2%.A test dose
of 3ml lidocaine 2% and epinephrine 1 : 200000 was injected
to rule out intravenous or subarachnoid injection.
In the dexamethasone group, patients received 18ml of
isobaric bupivacaine 0.5% and 2ml (8mg) of dexamethasone,
and in the control group, patients received 18ml of isobaric
bupivacaine 0.5% and 2ml of normal saline epidurally. The
end time of injection, the onset of sensory block with the
pinprick test at the site of surgery, presence or absence of
nausea, and vomiting in the first hour after the procedure
were noted. After the operation, the onset of pain perception
by the patients at the site of surgery was also recorded.
The onset of epidural anesthesia was defined as the time
interval between the end of drug injection and the total
abolition of pinprick response at the site of surgery. The
duration of epidural analgesia was defined as the time from
onset of sensory block up to pain perception at the site of
surgery by the patient at rest with the moving. Any unwanted
complication was recorded.
2.1. Sample Size. With regard to the onset of anesthesia in
both groups, with and without dexamethasone (14.5 ± 2.10
versus 18.15 ± 4.25min, resp.), based on previous studies [6],
and with a power of 80% and a significance level of 95%, a
sample size of 22 patients in each group was determined.
2.2. Data Analysis. Statistical analyses were performed using
Statistical Package for Social Science (SPSS) for Windows
version 19.0. Statistical tests such as Student’s 𝑡-test, the
Mann–Whitney 𝑈-test, and the chi-square test were used to
assess significant differences between the two groups.
3. Results
Forty-four patients were studied in the two groups, 22 in
each group. Demographic data and duration of surgery were
similar in both groups and all patients were males (Table 1).
The onset of anesthesia was significantlymore rapid in the
dexamethasone group than in the control group (𝑃 < 0.001).
The duration of analgesia was markedly prolonged in the
dexamethasone group than in the control group (𝑃 < 0.001)
(Table 2).
Only five (22.7%) of the patients had nausea in the first
hour after the procedure, and all were in the control group
(𝑃 = 0.048). None of the patients in the dexamethasone
group had nausea. None of the patients in either group had
vomiting (Table 2).
4. Discussion
In recent studies, steroids were added to local anesthetics to
enhance the duration of anesthesia and improve the quality
of analgesia in regional blocks. This combination was used
for subcutaneous infiltration, neuraxial route, and peripheral
nerve blocks [7, 11, 12].
In the study of Biradar et al. [13] in 2013, the addition
of dexamethasone (8mg) to the combination of lidocaine
1.5% and epinephrine 1 : 200000 in a supraclavicular block
substantially prolonged the duration of sensory and motor
block (326.0 ± 58.6 versus 159.0 ± 20.1 and 290.6 ± 52.7 versus
135.5 ± 20.3min, resp.).
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Kopacz et al. [14] showed that the combination of bupi-
vacaine and dexamethasone produces a prolonged duration
of anesthesia and analgesia in intercostal blockade. In a
randomized, controlled clinical study, Bigat et al. [15] added
8mg dexamethasone to lidocaine for intravenous regional
anesthesia (IVRA) in patients undergoing hand surgery.They
concluded that the addition of dexamethasone to lidocaine
for IVRA improves postoperative analgesia during the first
postoperative day.
In another study, Holte et al. [16] demonstrated that
subcutaneous injection of bupivacaine with dexamethasone
prolonged local analgesia compared with bupivacaine alone.
Furthermore, it has been shown that the addition of other
steroids such asmethylprednisolone to local anesthetics in an
axillary block considerably prolongs the duration of analgesia
and motor block [17].
The combination of dexamethasone and local anesthetic
has been used in the epidural space in some previous studies
in differentmanners. In order to assess the net effect of adding
dexamethasone to epidural local anesthetic on the duration
of postoperative analgesia, we only added dexamethasone
to epidural bupivacaine, and all our patients were male
and candidates for unilateral inguinal herniorrhaphy. We
showed that adding dexamethasone to epidural bupivacaine
significantly prolongs the duration of perioperative analgesia,
in addition to producing earlier onset of action.
Shrestha et al. [7] in 2007 compared addition of dex-
amethasone (8mg) or tramadol (2mg/kg) to epidural bupi-
vacaine, and the duration of postoperative analgesia was
substantially more in the dexamethasone group than in the
tramadol group (1028 and 453min, resp.).
The study of Naghipour et al. [18] in 2013 has indicated
that the addition of dexamethasone (8mg and 4mg in lumbar
and thoracic epidural catheterization, resp.) to bupivacaine
and fentanyl for postoperative epidural analgesia results in
an increased duration of analgesia (372 ± 58.1 versus 234.6
± 24.3min). The pain score and pentazocine use in the
dexamethasone group were less than those in the control
group (37.1 ± 19.7mg versus 73.1 ± 17.6mg, resp.; 𝑃 = 0.001).
Although the study used bupivacaine and dexamethasone
only for postoperative analgesia, the results confirm the
results of our study.
Hefni et al. [19] evaluated the efficiency and safety of
different doses of epidural dexamethasone for postoperative
analgesia. Patients received 10ml epidural plain bupivacaine
0.25% in the control group with 4mg, 6mg, and 8mg
dexamethasone in the other groups. After surgery, the time
to first analgesic requirement was significantly prolonged in
the dexamethasone groups compared with the control group.
There was a significant reduction in postoperative meperi-
dine consumption during the first 24 h in the dexamethasone
groups in comparison with the control group. The visual
analogue scale (VAS) scores were significantly lower and
the patient satisfaction score was significantly higher in the
dexamethasone groups compared with the control group.
Similar to our study, this finding showed that epidural dex-
amethasone reduces postoperative pain following surgery.
Results of our study showed that the complete sensory
block in the dexamethasone group was earlier than in the
control group (7.64 ± 2.74 versus 12.09 ± 2.79min).
Yadav et al. [9] in 2008 used 24ml lidocaine with 4mg
dexamethasone (𝑛 = 30) or neostigmine (𝑛 = 30) compared
with a control group (𝑛 = 30) in brachial plexus block
in 90 patients; the onset was better in the dexamethasone
group. The earlier onset of action in the steroid group may
be due to the synergistic action of dexamethasone with local
anesthetics on the blockage of nerve fibers [20, 21].
The mechanisms by which dexamethasone increased
the duration of nerve blockade and analgesic effect are
not fully understood, though it is commonly attributed to
anti-inflammatory and immunosuppressive actions. This is
supported by the finding that the block length is increased by
glucocorticoid potency and is completely reversed by admin-
istration of a specific glucocorticoid receptor antagonist [21,
22].
According to the traditional theory of steroid action,
glucocorticoids bind to intracellular receptors and modify
nuclear transcription [23]. In our study, dexamethasone had
a relatively rapid effect that cannot be explained by the above
mechanism.
Corticosteroids may have a local effect on the nerve.
It has been shown that local steroid application suppresses
transmission in thin unmyelinated nociceptive C-fibers, but
not in myelinated A-beta fibers [24]. The dexamethasone
effect in our study may be related to this action.
Furthermore, epidural dexamethasone may suppress
prostaglandin formation in the spinal cord. Peripheral tis-
sue damage during surgery activates phospholipase A2 and
upregulates the expression of cyclooxygenase-2 in the spinal
cord, leading to prostaglandin synthesis and a resultant
hyperalgesic state [25]. Inflammatory, metabolic, hormonal,
and immune responses to surgery are activated immediately
after the surgical incision, so preoperative administration
of steroids may reduce these responses, by their anti-
inflammatory and immunosuppressive effects and by inhibit-
ing both phospholipase A2 and cyclooxygenase-2 enzymes
[26].
Five (22.7%) of our patients in the control group had
nausea in the first hour after the procedure. None of the
patients in the dexamethasone group had nausea. This result
may be due to the antiemetic effect of dexamethasone, which
has been demonstrated in other studies using perioperative
corticosteroids [27–29].
Adverse effects with a single dose of dexamethasone are
extremely rare and slight in nature, and prior studies have
demonstrated that short-term (<24 hour) use of dexametha-
sone is safe [30, 31].
We used a dose of 8mg dexamethasone in lumbar
epidural anesthesia in our patients because administration of
this dose was deemed to be safe in adults; however, additional
studies must be done to determine the optimal dose of
epidural dexamethasone.
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